Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer clinical trial (NCT00534417). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this combination treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer clinical trial (NCT00534417). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of capecitabine and fulvestrant?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer clinical trial (NCT00534417). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer clinical trial (NCT00534417). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the treatment process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer clinical trial (NCT00534417). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks or concerns I should be aware of before participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer clinical trial (NCT00534417). Contact the study team or your healthcare provider for specific answers.

What this study is about